IP Library Granted Patent US 9,512,403
Granted Patent B2
US 9,512,403 · App. 14/011,672 · Granted Dec 6, 2016

Conditioned medium and extracellular matrix compositions from cells cultured under hypoxic conditions for methods of treating tissue injury

Inventors: Gail K. Naughton (San Diego, CA); Frank Ziegler (Encinitas, CA); Mark Baumgartner (San Diego, CA); Kyle Nickey (Vista, CA)
Assignee: Histogen, Inc.
C12N5/0662A61L27/227A61L27/3834A61L27/3895C07K14/47C12N5/0068C12N5/0627C12N5/0656A61K38/00C12N2500/02C12N2500/90C12N2533/90
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,512,403
App. No.
14/011,672
Granted
Dec 6, 2016
Kind
B2
Abstract

The present invention is directed to a method of producing compositions including embryonic proteins. The method includes culturing cells under hypoxic conditions on a biocompatible surface in vitro. The culturing method produces both soluble and non-soluble fractions, which may be used separately or in combination to obtain physiologically acceptable compositions useful in a variety of medical and therapeutic applications.

Claims (12)

1. A method of producing a composition for treating tissue in need of repair comprising:

culturing fibroblast cells under hypoxic conditions on a microcarrier bead surface in a suitable growth medium, under 1-5% oxygen for at least 2 weeks, thereby producing multipotent stem cells, wherein the multipotent stem cells produce and secrete a composition that promotes repair and regeneration of damaged tissue when administered to the region of tissue in need of repair in a subject and collecting the growth medium after the 2 weeks, thereby producing the composition.

2. A composition produced by the method of claim 1 .

3. A method of treating damaged tissue comprising contacting the damaged tissue with a composition made by the method of claim 1 under conditions that allow for treatment of the damaged tissue.

4. The method of claim 1 , wherein the tissue is connective tissue.

5. The method of claim 3 , wherein the tissue is connective tissue.

6. The method of claim 4 , wherein the tissue is bone, cartilage, ligament, tendon, meniscus, dermis, hyperdermis, muscle, fatty tissue, joint capsule, intestinal or heart tissue.

7. The method of claim 5 , wherein the tissue is bone, cartilage, ligament, tendon, meniscus, dermis, hyperdermis, muscle, fatty tissue, joint capsule, intestinal or heart tissue.

8. The method of claim 6 , wherein the tissue is infarcted or ischemic tissue.

9. The method of claim 7 , wherein the tissue is infarcted or ischemic tissue.

10. A method for improvement of a skin surface in a subject comprising administering to the subject at the site of a wrinkle or scar, a composition made by the method of claim 1 , thereby providing an improved skin surface.

11. A method for soft tissue repair or augmentation in a subject comprising administering to the subject at the site in need of repair, a composition made by the method of claim 1 , thereby providing soft tissue repair or augmentation.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 30, 2024
From: HISTOGEN INC.
To: ALLERGAN SALES, LLC
Reel/Frame 067559/0977 →
Continuity (8)
Continuation 12547422 · Aug 25, 2009
Continuation In Part 12509171 · Jul 24, 2009
Continuation In Part 12501312 · Jul 10, 2009
Continuation In Part 13363488 · Jan 30, 2009
Provisional Application 61050940 · May 6, 2008
Provisional Application 61034361 · Mar 6, 2008
Provisional Application 61024854 · Jan 30, 2008
Related Publication 20130344161A1 · Dec 26, 2013